Skip to main content
. 2014 May 2;29(9):1686–1695. doi: 10.1093/ndt/gfu088

Table 2.

Analysis of general demographics by sex and Nglom in African and Caucasian Americans

  Females
Model 1 for males
(matched to females by age and Nglom)
Model 2 for males
(matched to females by age, Nglom and BSA)
Age
(years)
Nglom
(million)
HTN
(proportion; %)
Rx HTN
(proportion; %)
Age
(years)
Nglom
(million)
HTN
(proportion; %)
Rx HTN
(proportion; %)
Age
(years)
Nglom
(million)
HTN
(proportion; %)
Rx HTN
(proportion; %)
African Americans (n = 32) High Nglom 38 1.16 0/6; 0% 0/0; 0% 37.0NS 1.18NS 2/6; 33% 2/6; 33% 30.5NS 1.17NS 2/6; 33% 2/6; 33%
(28–49) (1.1–1.3) NA NA (27–43) (1.1–1.3) NA NA (21–43) (1.1–1.3) NA NA
Low Nglom 38.5 0.59 4/6; 67% 3/6; 50% 39.0NS 0.59NS 4/6; 67% 3/6; 50% 40.0NS 0.53NS 4/6; 67% 2/6; 33%
(28–50) (0.5–0.6) NA NA (35–53) (0.5–0.6) NA NA (34–54) (0.5–0.6) NA NA
Caucasian Americans (n = 34) High Nglom 45.5 1.1 0/6; 0% 0/0; 0% 44.0NS 1.11NS 1/6; 17% 1/6; 17% 47.5NS 1.04NS 1/6; 17% 1/6; 17%
(38–50) (1.1–1.2) NA NA (39–59) (0.9–1.2) NA NA (38–61) (0.9–1.2) NA NA
Low Nglom 46.5 0.46 2/6; 33% 1/6; 17% 40.5NS 0.56NS 3/6; 50% 1/6; 17% 51.5NS 0.58NS 3/6; 50% 3/6; 50%
(39–55) (0.4–0.5) NA NA (37–48) (0.3–0.6) NA NA (39–57) (0.4–0.6) NA NA

Values for age and Nglom are expressed as median (inter quartile range). HTN (HTN: hypertensive status) is expressed as a proportion and percentage of hypertensive subjects; Rx HTN (history of prescribed anti-hypertensive medication), which is expressed as a proportion and percentage of subjects receiving anti-hypertensive therapy to control blood pressure; Nglom: total nephron number; NSP > 0.05; all statistical comparisons were performed between females and model 1 for males and between females and model 2 for males; NA, not applicable.